Skip to main content
. 2008 Oct 16;38(11):777–785. doi: 10.1093/jjco/hyn101

Table 2.

Response rate

Total Platinum sensitive Platinum resistant
Number of patients 73 11 62
Best overall response: n (%)
 CR 2 (2.7) 0 (0.0) 2 (3.2)
 PR 14 (19.2) 3 (27.3) 11 (17.7)
 SD 28 (38.4) 3 (27.3) 25 (40.3)
 PD 27 (37.0) 4 (36.4) 23 (37.1)
 NE 2 (2.7) 1 (9.1) 1 (1.6)
Response rate
n (%) (95% CI) 16 (21.9) (13.1–33.1) 3 (27.3) (6.0–61.0) 13 (21.0) (11.7–33.2)

CR, complete response; PR, partial response; SD, stable disease; PD, progression disease; NE, not evaluable; 95% CI, confidence interval.